Holen Sie sich die Stockscreener-App
78.82
3.31%
-2.70
Vorhandelsmarkt:
78.82
Schlusskurs vom Vortag:
$81.52
Offen:
$81.15
24-Stunden-Volumen:
219.88K
Relative Volume:
1.12
Marktkapitalisierung:
$1.77B
Einnahmen:
$213.03M
Nettoeinkommen (Verlust:
$41.32M
KGV:
43.07
EPS:
1.83
Netto-Cashflow:
$33.49M
1W Leistung:
-4.45%
1M Leistung:
-18.73%
6M Leistung:
-12.12%
1J Leistung:
+18.33%
1-Tages-Spanne:
$78.79
$82.42
1-Wochen-Bereich:
$78.79
$84.46
52-Wochen-Spanne:
$62.39
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Vergleichen Sie LMAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
78.82 | 1.77B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
476.78 | 170.05B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
222.79 | 63.97B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
86.81 | 42.94B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
219.72 | 32.28B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
34.55 | 17.64B | 17.28B | 108.00M | 391.00M | 0.20 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
Down -15.37% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround - Nasdaq
Smartleaf Asset Management LLC Buys 293 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Bank of New York Mellon Corp Lowers Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) PT at $95.25 - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Will Pay A Larger Dividend Than Last Year At $0.20 - Yahoo Finance
LeMaitre Vascular's (NASDAQ:LMAT) Shareholders Will Receive A Bigger Dividend Than Last Year - Simply Wall St
Ex-Dividend Reminder: LeMaitre Vascular, Mercury General and CBL & Associates Properties - Nasdaq
(LMAT) Investment Analysis - Stock Traders Daily
Geneva Capital Management LLC Has $79.76 Million Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Bahl & Gaynor Inc. Has $11.26 Million Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Independent Director Lawrence Jasinski Sold A Bunch Of Shares In LeMaitre Vascular - Simply Wall St
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Looks Like A Good Stock, And It's Going Ex-Dividend Soon - Yahoo Finance UK
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
LeMaitre Vascular director sells $289,064 in stock By Investing.com - Investing.com South Africa
LeMaitre Vascular, Inc. to Host Earnings Call - ACCESS Newswire
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces Dividend Increase$0.20 Per Share - MarketBeat
Q3 Earnings Estimate for LMAT Issued By Barrington Research - MarketBeat
LeMaitre (LMAT) Upgraded to Buy: Here's What You Should Know - MSN
Insider Sell: Lawrence Jasinski Sells Shares of LeMaitre Vascula - GuruFocus.com
LeMaitre Vascular director sells $289,064 in stock - Investing.com
3 Best Earnings Growth Stocks to Buy in March: CAKE, LMAT, HURN - Yahoo Finance
Sanctuary Advisors LLC Has $207,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
13,432 Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) Acquired by Illumine Investment Management LLC - MarketBeat
Principal Financial Group Inc. Boosts Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Shares Gap DownHere's What Happened - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Stock Price Expected to Rise, Lake Street Capital Analyst Says - MarketBeat
Best Momentum Stocks to Buy for March 4th - Nasdaq
Stentless Bioprostheses Market Is Booming Worldwide 2025-2032 - openPR
LeMaitre Vascular (NASDAQ:LMAT) Posts Quarterly Earnings Results, Hits Estimates - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Updates Q1 2025 Earnings Guidance - MarketBeat
LeMaitre to Participate at Upcoming Investor Conferences in March - GlobeNewswire
LeMaitre Vascular (NASDAQ:LMAT) Updates FY 2025 Earnings Guidance - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Lowered to Market Perform Rating by Oppenheimer - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Cut to Market Perform at Barrington Research - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Cut to “Market Perform” at Barrington Research - Defense World
LeMaitre Vascular (NASDAQ:LMAT) Cut to “Market Perform” at Oppenheimer - Defense World
LeMaitre Vascular (NASDAQ:LMAT) Price Target Raised to $110.00 - Defense World
Truist Financial Corp Has $822,000 Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Earnings Update: Here's Why Analysts Just Lifted Their LeMaitre Vascular, Inc. (NASDAQ:LMAT) Price Target To US$105 - Simply Wall St
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.47%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):